申请人:Jablonski Philippe
公开号:US20090306043A1
公开(公告)日:2009-12-10
The present invention relates to compounds of formula I
wherein R
1
, R
2
, R
3
, R′, Ar, m, n, and o are as defined herein. The invention also relates to pharmaceutical compositions containing compounds of formula I and methods for the manufacture of such compounds and compositions. Compounds of the invention are high potential NK-3 receptor antagonists for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).
本发明涉及式I的化合物,其中R1、R2、R3、R′、Ar、m、n和o如本文所定义。该发明还涉及含有式I化合物的药物组合物,以及制备这种化合物和组合物的方法。本发明的化合物是用于治疗抑郁症、疼痛、精神病、帕金森病、精神分裂症、焦虑和注意力缺陷多动障碍(ADHD)的高潜力NK-3受体拮抗剂。